Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases
AON-platform with focus on therapies nearing phase I trials for forms of Spinocerebellar Ataxia and Huntington Disease Other early discovery stage RNA editing platform focuses on RETT syndrome Funding led by LSP, co-led by Kurma Partners, supported b... Biopharmaceuticals, Neurology, Venture Capital Vico Therapeutics, RNA modulating therapies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 29, 2020 Category: Pharmaceuticals Source Type: news

New maps of chemical marks on DNA pinpoint regions relevant to many developmental diseases
(Salk Institute) In research that aims to illuminate the causes of human developmental disorders, Salk scientists have generated 168 new maps of chemical marks on strands of DNA -- called methylation -- in developing mice. The data can help narrow down regions of the human genome that play roles in diseases such as schizophrenia and Rett Syndrome. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 29, 2020 Category: Biology Source Type: news

Genetic editing milestone in mouse model of Rett Syndrome
(Rett Syndrome Research Trust) A genomic error that causes Rett Syndrome, a serious lifelong neurological disorder, can be corrected in the brains of mice by rewriting the genetic instructions carried by the RNA.The new research, published July 14 in the journal Cell Reports, shows that RNA editing may repair the underlying cause of Rett Syndrome in a mouse model. The technology recoded enough RNA to restore half of the normal protein in three different kinds of neurons in the Rett mouse. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2020 Category: International Medicine & Public Health Source Type: news

Genetic Editing Milestone in Mouse Model of Rett Syndrome
A genomic error that causes Rett Syndrome, a serious lifelong neurological disorder, can be corrected in the brains of mice by rewriting the genetic instructions carried by the RNA.The new research,...(PRWeb July 14, 2020)Read the full story at https://www.prweb.com/releases/genetic_editing_milestone_in_mouse_model_of_rett_syndrome/prweb17255912.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 14, 2020 Category: Pharmaceuticals Source Type: news

URMC Tapped to Advance Research in Intellectual and Developmental Disabilities
The University of Rochester has been designated an Intellectual and Developmental Disabilities Research Center by the National Institute of Child Health and Human Development. The award recognizes the Medical Center ’s national leadership in research for conditions such Autism, Batten disease, and Rett syndrome, will translate scientific insights into new ways to diagnose and treat these conditions, and provide patients and families access to cutting edge care. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - July 8, 2020 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Yale researchers find potential treatment for Rett syndrome
An experimental cancer drug can extend the life of mice with a devastating genetic disorder, Yale researchers report. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 10, 2020 Category: Universities & Medical Training Source Type: news

What Is the Life Expectancy Rett Syndrome
What Is the Life Expectancy of a Person with Rett Syndrome? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 31, 2020 Category: General Medicine Source Type: news

Twins, 17-months-old, are the first in Britain to both be diagnosed with an incurable brain disease
Amelia and Ruby Sampson, from Birmingham, have Rett syndrome. They may not make it to adulthood. Rett claimed the life of Coleen Rooney's sister Rosie McLoughin aged 14. (Source: the Mail online | Health)
Source: the Mail online | Health - February 13, 2020 Category: Consumer Health News Source Type: news

Research team investigates abnormal neuron activity in Rett syndrome
(University of Tennessee at Knoxville) Research by Billy Lau, a postdoctoral researcher working with Assistant Professor Keerthi Krishnan at the University of Tennessee, Knoxville, examines the time during which an adult female mouse first learns to recognize and respond to the distress cries of young mouse pups as an opportunity for the brain to rewire and learn again. The findings hint at potential therapeutic strategies for Rett syndrome, a rare neurodevelopmental disorder. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2020 Category: International Medicine & Public Health Source Type: news

Heartwarming moment woman who has never been able to talk tell her mother 'I love you'
Pauline Worrall, from Kidderminster, was robbed of her movement and speech at the age of two at the hands of Rett syndrome, a rare brain disease that affects one in 12,000 kids. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2020 Category: Consumer Health News Source Type: news

A dietary supplement improves skills of an atypical Rett syndrome patient
(IDIBELL-Bellvitge Biomedical Research Institute) Administration of the amino acid L-serine, a dietary supplement, contributes to the improvement of the communicative and motor skills of a patient with a mutation that alters glutamate receptors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 18, 2019 Category: International Medicine & Public Health Source Type: news

Novel Drug Promising for Life-Threatening Rett Syndrome in Kids Novel Drug Promising for Life-Threatening Rett Syndrome in Kids
Now under development, trofinetide could eventually fill the critical need for a safe and effective treatment for the life-threatening Rett syndrome in children and teens.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 9, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

The girl who will never grow up because of rare genetic condition
Penny Stewart, from Blyth in Northumberland, was just two years old when she was robbed of her movement and speech. She was diagnosed with Rett syndrome after two years of tests. (Source: the Mail online | Health)
Source: the Mail online | Health - March 4, 2019 Category: Consumer Health News Source Type: news

Rett Syndrome Research Trust Awards $10 Million to Preeminent...
Thanks to a $10 million investment in Rett Syndrome research in 2018 - the largest annual award since the organization was founded in 2008 - the Rett Syndrome Research Trust (RSRT) is fueling exciting...(PRWeb January 23, 2019)Read the full story at https://www.prweb.com/releases/rett_syndrome_research_trust_awards_10_million_to_preeminent_researchers_in_pursuit_of_curing_devastating_neurological_disorder/prweb16051173.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 23, 2019 Category: Pharmaceuticals Source Type: news

Rett Syndrome Research Trust Names Timothy A. Riley Chief Scientific...
The Rett Syndrome Research Trust (RSRT) is delighted to announce that Timothy A. Riley, Ph.D. has joined the organization in the role of Chief Scientific Officer and Chief Business Officer. Randall...(PRWeb September 26, 2018)Read the full story at https://www.prweb.com/releases/rett_syndrome_research_trust_names_timothy_a_riley_chief_scientific_officer_and_chief_business_officer_randall_carpenter_transitions_to_chief_medical_officer/prweb15788279.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 26, 2018 Category: Pharmaceuticals Source Type: news

Deep Brain Stimulation Affects the Activity of Hundreds of Genes
Changes in gene activity levels after DBS appear to underlie improvements seen in a mouse model of Rett syndrome, a genetic disease that causes intellectual disability. (Source: The Scientist)
Source: The Scientist - May 14, 2018 Category: Science Tags: Daily News,The Scientist Source Type: news

A new drug shows preclinical efficacy in Rett syndrome
(IDIBELL-Bellvitge Biomedical Research Institute) A new article published in the Cell Reports describes how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett Syndrome in preclinical models. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 14, 2018 Category: Biology Source Type: news

David Geffen School Medicine at UCLA presents award for excellence in basic science research
Dr. Huda Zoghbi, a Baylor College of Medicine professor whose work holds promise for treating a range of neurological and neuropsychiatric disorders, received an annual award for excellence in biological and biomedical sciences research from theDavid Geffen School of Medicine at UCLA.The medical school ’s dean, Dr. Kelsey Martin, presented Zoghbi with the 2017Switzer Prize during a Feb. 16 ceremony. Zoghbi received a $25,000 honorarium and a statuette.“Her story is a beautiful illustration of the connection between medicine and science, and a lesson in the value of maintaining curiosity and open-mindedness,&rdq...
Source: UCLA Newsroom: Health Sciences - February 17, 2018 Category: Universities & Medical Training Source Type: news

David Geffen School of Medicine at UCLA presents award for excellence in basic science research
Dr. Huda Zoghbi, a Baylor College of Medicine professor whose work holds promise for treating a range of neurological and neuropsychiatric disorders, received an annual award for excellence in biological and biomedical sciences research from theDavid Geffen School of Medicine at UCLA.The medical school ’s dean, Dr. Kelsey Martin, presented Zoghbi with the 2017Switzer Prize during a Feb. 16 ceremony. Zoghbi received a $25,000 honorarium and a statuette.“Her story is a beautiful illustration of the connection between medicine and science, and a lesson in the value of maintaining curiosity and open-mindedness,&rdq...
Source: UCLA Newsroom: Health Sciences - February 17, 2018 Category: Universities & Medical Training Source Type: news

Rett syndrome: Woman fundraises for three-year-old daughter
Sophie Edes cannot talk due to the rare syndrome. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 3, 2018 Category: Consumer Health News Source Type: news

Researchers reverse symptoms in neurologic disease model
(Case Western Reserve University) Rett syndrome is a devastating genetic, neurologic disorder that typically affects girls, resulting in severe disability and often accompanied by autistic behavior. Most Rett patients will live into middle age and require specialized full-time care. There is no cure, but researchers from Case Western Reserve University School of Medicine have been working to find ways to restore brain function and reverse disabilities associated with Rett syndrome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2018 Category: International Medicine & Public Health Source Type: news

James Wilson, MD, PhD, from the University of Pennsylvania, Joins the...
The Rett Syndrome Research Trust (RSRT) is pleased to announce that James Wilson, MD, PhD, director of the University of Pennsylvania Gene Therapy Program and the Rose H. Weiss Orphan Disease Center,...(PRWeb January 26, 2018)Read the full story at http://www.prweb.com/releases/2018/01/prweb15132993.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 26, 2018 Category: Pharmaceuticals Source Type: news

X chromosome reactivation could treat Rett syndrome, other X-linked disorders
(Massachusetts General Hospital) A study from a team of Massachusetts General Hospital investigators points toward a potential strategy for treating X-linked disorders -- those caused by mutations in the X chromosome -- in females. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 4, 2018 Category: International Medicine & Public Health Source Type: news

Neuren to conduct first phase 3 clinical trial for Rett Syndrome
(Rettsyndrome.org) Rettsyndrome.org is pleased to share that Neuren Pharmaceuticals, today, after meeting with the FDA, will conduct a Phase 3 clinical trial for trofinetide, a compound that shows great promise in the treatment of Rett syndrome, in children and adults. This critical Phase 3 trial will be the final clinical step before FDA approval to become a prescribable drug. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 12, 2017 Category: Biology Source Type: news

What Causes Microcephaly?
Patient Presentation A 5-month-old male came to clinic for his health supervision visit and followup from his neonatal intensive care stay. He was born prematurely at 28 weeks gestation and his stay was complicated by a right sided Grade III intraventricular hemorrhage, a left-sided Grade IV intraventricular hemorrhage, neonatal seizures, respiratory distress and bronchopulmonary dysplasia, retinopathy of prematurity, acute kidney injury that had resolved, possible necrotizing enterocolitis incidents x 2, and herpes simplex encephalitis. He was on home oxygen, a nasogastric feeding tube because of aspiration risk and mult...
Source: PediatricEducation.org - September 25, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Discovery fuels hope for Rett syndrome treatment
(Vanderbilt University Medical Center) Vanderbilt University researchers have relieved symptoms of Rett syndrome in a mouse model with a small molecule that works like the dimmer switch in an electrical circuit. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 23, 2017 Category: International Medicine & Public Health Source Type: news

Drug improves brain performance in Rett syndrome mice
(University of Alabama at Birmingham) A brain penetrant drug -- a small-molecule mimetic of BDNF, or brain derived neurotrophic factor -- is able to improve brain performance in Rett syndrome mice -- specifically synaptic plasticity in the hippocampus and object location memory. The hippocampus is involved in learning and memory. The drug also increased the distance mice traveled in an open field test, a measure of general locomotor activity, to normal levels. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 27, 2017 Category: International Medicine & Public Health Source Type: news

Seven lessons I ’ve learned from Rett syndrome
As a mother of a child with Rett syndrome, a disability that affects the brain’s ability to plan or coordinate motor skills, the phrase “take for granted” takes on a whole new meaning. I cannot take for granted that Ava can recite her A, B, C’s or feed herself a snack or go to the bathroom on her own. Quite the opposite. Every day, I strive to properly appreciate the effort it takes for Ava to perform the most mundane tasks. I am the one being “schooled” on Rett syndrome. Here are seven of the things Rett syndrome has taught me: 1. Technology is seriously cool.  Ava doesn’t sp...
Source: Thrive, Children's Hospital Boston - July 18, 2017 Category: Pediatrics Authors: Joanne Gryniewicz Tags: Our Patients’ Stories rett syndrome Source Type: news

Biohaven's BHV-5000 Receives Orphan Drug Designation from the FDA in Rett Syndrome
NEW HAVEN, Conn., July 6, 2017 -- (Healthcare Sales & Marketing Network) -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced today that BHV-5000, an investigational compound in the company's glutamate modulation platform, has been grant... Biopharmaceuticals, Neurology, FDA Biohaven Pharmaceutical, BHV-5000, Rett syndrome, orphan drug designation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 6, 2017 Category: Pharmaceuticals Source Type: news

Personalized metabolic therapy treatment shows improvement on atypical Rett syndrome
(IDIBELL-Bellvitge Biomedical Research Institute) Administration of the amino acid D-serine, a dietary supplement, contributes to the improvement of the cognitive and motor capacity of a patient with a mutation that affects glutamate receptors (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 4, 2017 Category: International Medicine & Public Health Source Type: news

David Geffen School of Medicine at UCLA names winner of Switzer Prize for research excellence
Dr. Huda Zoghbi, a neurologist whose work has revealed the molecular basis of neurological disorders, is the recipient of the 2017 Switzer Prize awarded by theDavid Geffen School of Medicine at UCLA for excellence in biological and biomedical sciences research.Zoghbi ’s lab at the Baylor College of Medicine identified a gene mutation that causes Rett syndrome, a severe genetic disorder that mostly affects girls. After a short period of apparently normal development, the disorder causes them to lose language and motor skills, typically by 18 months of age. The discovery paved the way for a genetic test to diagnose the...
Source: UCLA Newsroom: Health Sciences - June 19, 2017 Category: Universities & Medical Training Source Type: news

A Vote To Gut Medicaid Is A Vote Against Families
In response to imminent threats to Medicaid, The Arc produced a series of videos which share personal stories of people with disabilities and their families, and highlight the vital importance of Medicaid in gaining access to the home and community based supports and services needed to live independent and fulfilling lives. Meet Soojung. Her 11 year-old daughter, Alice, has Rett Syndrome and relies on overnight nursing services to be able to live at home with her family. Watch as Linda from North Carolina tells the story of how Medicaid changed her son Javi’s life. Listen to Bryan tell his story abou...
Source: Healthy Living - The Huffington Post - June 14, 2017 Category: Consumer Health News Source Type: news

AveXis to Advance Gene Therapy Program Initiated by the Rett Syndrome...
The Rett Syndrome Research Trust (RSRT) is excited to announce that AveXis, Inc., has committed to advance a gene therapy candidate for Rett Syndrome into human clinical trials.(PRWeb June 08, 2017)Read the full story at http://www.prweb.com/releases/2017/06/prweb14408379.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 8, 2017 Category: Pharmaceuticals Source Type: news

Living with Rett syndrome, living with hope
For the first year of her life, Ava Gryniewicz seemed to be developing like any other happy baby. She had learned a few words, including “mama” and “dada,” and was picking up Cheerios with pincer fingers. But by the time she was 14 months old, everything had changed. Ava started to lose these skills and wasn’t reaching other milestones. At the recommendation of her daycare center, she started early intervention. “She wasn’t keeping up and her daycare providers were concerned that standard daycare might be too much for her,” says her mom, Joanne. That’s when Joanne and h...
Source: Thrive, Children's Hospital Boston - June 1, 2017 Category: Pediatrics Authors: Ellen Greenlaw Tags: Our Patients’ Stories Alycia Berg Augmentative communication Dr. Jonathan Picker rett syndrome Rett Syndrome Program Suzanne Rose Source Type: news

Rettsyndrome.org funds additional $775K of new research projects in Q1 2017
(Rettsyndrome.org) The International Rett Syndrome Foundation, now doing business as Rettsyndrome.org, announces the addition of six research projects to its Research Portfolio in the first quarter of 2017. A commitment of $775,000, through research grants, brings the largest non-governmental private funder of Rett research above the recently attained milestone of $40M research dollars to $41M. These funds have continually been designated to accelerate research for Rett syndrome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2017 Category: Global & Universal Source Type: news

Sustained attention in the face of distractors: a study of children with Rett syndrome - Rose SA, Wass S, Jankowski JJ, Feldman JF, Djukic A.
OBJECTIVE: The object of the present study is to advance our understanding of the cognitive profile of Rett syndrome (RTT), an X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene. We focus on sustained attention, which plays a critic... (Source: SafetyLit)
Source: SafetyLit - April 11, 2017 Category: Global & Universal Tags: Age: Infants and Children Source Type: news

Neuren reports positive top-line results from Phase II trial of trofinetide for Rett syndrome
Australian-based biopharmaceutical firm Neuren Pharmaceuticals has reported positive top-line results from the Phase II clinical trial of trofinetide to treat girls with Rett syndrome. (Source: Drug Development Technology)
Source: Drug Development Technology - March 27, 2017 Category: Pharmaceuticals Source Type: news

The Rett Syndrome Research Trust Announces Roadmap to Cure Devastating...
Human clinical trials of gene therapy on the horizon.(PRWeb March 22, 2017)Read the full story at http://www.prweb.com/releases/2017/03/prweb14176403.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 23, 2017 Category: Pharmaceuticals Source Type: news

Scientists Uncover Possible Therapeutic Targets for Rare Autism Spectrum Disorder
Researchers have uncovered 30 genes that could, one day, serve as therapeutic targets to reverse Rett syndrome, a rare neurological disorder that affects only girls and is a severe form of an autism spectrum disorder. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 31, 2017 Category: Science Source Type: news

In Rett syndrome model, team shows how adult learning is impaired in females
In mouse models of Rett syndrome -- which in humans is seen overwhelmingly in females -- researchers have demonstrated how failure of Mecp2, the mouse equivalent of the human gene of the same name, has biological consequences that prevent adult females from learning how to gather newborn pups in the days immediately following the pups'birth. They reversed the defect. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 18, 2017 Category: Science Source Type: news

In Rett syndrome model, team shows how adult learning is impaired in females
(Cold Spring Harbor Laboratory) In mouse models of Rett syndrome -- which in humans is seen overwhelmingly in females -- researchers have demonstrated how failure of Mecp2, the mouse equivalent of the human gene of the same name, has biological consequences that prevent adult females from learning how to gather newborn pups in the days immediately following the pups' birth. They reversed the defect. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 18, 2017 Category: Global & Universal Source Type: news

Rettsyndrome.org reaches milestone of $40 million in research funding
(Rettsyndrome.org) The International Rett Syndrome Foundation, now doing business as Rettsyndrome.org, announces today that Rettsyndrome.org has reached a milestone in research funding. The leading foundation for Rett research has distributed over $40 million dollars to accelerate treatments for Rett syndrome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 9, 2017 Category: Global & Universal Source Type: news

Neuren Pharmaceuticals completes enrolment for Phase II trial of trofinetide to treat Rett syndrome
US-based biopharmaceutical company Neuren has completed enrolment for its Phase II clinical trial of trofinetide in pediatric Rett syndrome. (Source: Drug Development Technology)
Source: Drug Development Technology - November 15, 2016 Category: Pharmaceuticals Source Type: news

Ed Sheeran serenades a nine-year-old superfan at her hospital bed  
Rocker Ed Sheeran has made a young superfan's dream come true by visiting her in hospital in Surrey to serenade her. Melody Driscoll, nine, suffers from the rare brain condition, Rett syndrome. (Source: the Mail online | Health)
Source: the Mail online | Health - November 10, 2016 Category: Consumer Health News Source Type: news

Newron begins STARS study of sarizotan to treat Rett syndrome
Italian-based biopharmaceutical company Newron Pharmaceuticals has begun the Sarizotan Treatment of Apneas in Rett Syndrome (STARS) study of sarizotan to treat Rett syndrome. (Source: Drug Development Technology)
Source: Drug Development Technology - July 25, 2016 Category: Pharmaceuticals Source Type: news

Insights into neurons that cause symptoms of Rett syndrome could guide new therapy search
Two studies in mice reveal new insights into neurons that mediate symptoms typical of the postnatal neurological disorder Rett syndrome. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 28, 2016 Category: Science Source Type: news

Insights into neurons that cause symptoms of Rett syndrome could guide new therapy search
(eLife ) Two studies in mice from Baylor College of Medicine, Texas, reveal new insights into neurons that mediate symptoms typical of the postnatal neurological disorder Rett syndrome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2016 Category: Global & Universal Source Type: news

i-Fect used to Study Epigenetics in Nerve Injury
Conclusions: The study shows a regulatory role for MeCP2 in that changes in global redistribution can result in direct and indirect modulation of gene expression in the DRG. Alterations in genome-wide binding of MeCP2 therefore provide a molecular basis for a better understanding of epigenetic regulation-induced molecular changes underlying nerve injury. (Source: siRNA and DsiRNA Transfection Efficiency)
Source: siRNA and DsiRNA Transfection Efficiency - June 20, 2016 Category: Neuroscience Tags: i-Fect MeCP2 Methyl-CpG-binding protein 2 miR-126 miRNA Delivery Methods Nerve Injury. Source Type: news

MeCP2 and Nerve Injury
Conclusions: The study shows a regulatory role for MeCP2 in that changes in global redistribution can result in direct and indirect modulation of gene expression in the DRG. Alterations in genome-wide binding of MeCP2 therefore provide a molecular basis for a better understanding of epigenetic regulation-induced molecular changes underlying nerve injury. (Source: Neuromics)
Source: Neuromics - June 20, 2016 Category: Neuroscience Tags: Delivering siRNA to the CNS epigenetics gene expression analysis i-Fect MECP2 methyl-CpG-binding protein 2 miR-126 Nerve Injury Nerve Sprouting Source Type: news

Dad Fights For Cure For His Daughter's Disorder In Emotional Video
In August 2014, dad A.J. Tesler created a short video with the title "Save My Daughter. Share This Video." Eight months earlier, his toddler daughter Magnolia (aka "Maggie") had been diagnosed with a rare neurological disorder called Rett syndrome, and all YouTube ad revenue generated from the video would go toward funding clinical trial research to find a cure. Now the dad is continuing his fight to find a cure -- for his daughter and the 350,000 other girls and women affected by Rett syndrome. The debilitating disorder almost exclusively affects girls and generally involves slowed developmen...
Source: Science - The Huffington Post - May 18, 2016 Category: Science Source Type: news